Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study

Golla, Rithvik; Vuyyuru, Sudheer K.; Kante, Bhaskar; Kumar, Peeyush; Mathew, David Thomas; Makharia, Govind; Kedia, Saurabh; Ahuja, Vineet

doi:10.1016/j.cgh.2022.10.015

Cited by 40 publications

(44 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such a high frequency of development of post-COVID-19 DGBI in that study might be related to recruitment bias as only 164 of 1114 subjects participated in the follow-up study. Two other studies published recently, one from India and the other multicentric (GI-COVID-19 study), showed the occurrence of post-COVID-19 FGID (now called DGBI) after the occurrence of COVID-19 [38,60]. In the Indian study, the frequency of post-COVID-19 IBS during six-month follow-up was 7% [38].…”

Section: Level Of Evidence: Ii-2mentioning

confidence: 86%

“…However, in a recent study, about 10% of patients with PI-IBS undergoing work-up were found to have tropical sprue despite fulfilling Rome criteria for IBS [26]. In another recently published study among patients with post-COVID-19 IBS, mucosal malabsorption documented by abnormal d-xylose test alone was present in 30% and by two abnormal tests (abnormal d-xylose test and low serum vitamin B 12 ) in 4% of patients [38]. A study from the USA also showed the occurrence of both PI-IBS and tropical sprue following acute gastroenteritis among army personnel posted in the Iraq war suggesting a common link between the two conditions [56].…”

Section: Statement 7: Gastrointestinal Infection With Varied Pathogen...mentioning

confidence: 94%

“…Two other studies published recently, one from India and the other multicentric (GI-COVID-19 study), showed the occurrence of post-COVID-19 FGID (now called DGBI) after the occurrence of COVID-19 [38,60]. In the Indian study, the frequency of post-COVID-19 IBS during six-month follow-up was 7% [38]. In the other multicentric study, 3.2% of hospitalized patients with COVID-19 developed IBS by Rome IV criteria during 12-month follow-up [60].…”

Section: Level Of Evidence: Ii-2mentioning

confidence: 96%

“…Though infection and infestations are common in developing countries, including India, the studies on the development of PI-IBS from India are scanty. Of the four available studies on this issue from the Indian authors, one was entirely performed in a population in Bangladesh [26], a country with similar socio-cultural factors and environment (Table 4) [26,[37][38][39]. Two of the recent studies were done among patients with COVID-19 [37,38].…”

Section: Statement 7: Gastrointestinal Infection With Varied Pathogen...mentioning

confidence: 99%

“…Of the four available studies on this issue from the Indian authors, one was entirely performed in a population in Bangladesh [26], a country with similar socio-cultural factors and environment (Table 4) [26,[37][38][39]. Two of the recent studies were done among patients with COVID-19 [37,38]. All the studies showed that the development of PI-IBS was common following acute GI infection and COVID-19.…”

Section: Statement 7: Gastrointestinal Infection With Varied Pathogen...mentioning

confidence: 99%

See 4 more Smart Citations

Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology

Ghoshal

Sachdeva

Pratap

et al. 2023

Indian J Gastroenterol

View full text Add to dashboard Cite

The Indian Neurogastroenterology and Motility Association (INMA), earlier named the Indian Motility and Functional Diseases Association developed this evidence-based practice guidelines for the management of irritable bowel syndrome (IBS). A modified Delphi process was used to develop this consensus containing 28 statements, which were concerning diagnostic criteria, epidemiology, etiopathogenesis and comorbidities, investigations, lifestyle modifications and treatments. Owing to the Coronavirus disease-19 (COVID-19) pandemic, lockdowns and mobility restrictions, web-based meetings and electronic voting were the major tools used to develop this consensus. A statement was regarded as accepted when the sum of “completely accepted” and “accepted with minor reservation” voted responses were 80% or higher. Finally, the consensus was achieved on all 28 statements. The consensus team members are of the view that this work may find use in teaching, patient care, and research on IBS in India and other nations.

show abstract

Section: Level Of Evidence: Ii-2mentioning

confidence: 86%

Section: Statement 7: Gastrointestinal Infection With Varied Pathogen...mentioning

confidence: 94%

Section: Level Of Evidence: Ii-2mentioning

confidence: 96%

Section: Statement 7: Gastrointestinal Infection With Varied Pathogen...mentioning

confidence: 99%

Section: Statement 7: Gastrointestinal Infection With Varied Pathogen...mentioning

confidence: 99%

See 3 more Smart Citations

Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology

Ghoshal

Sachdeva

Pratap

et al. 2023

Indian J Gastroenterol

View full text Add to dashboard Cite

show abstract

Clinical features of Japanese patients with gastrointestinal long‐COVID symptoms

Yagi,

Asakura,

Terai

et al. 2023

JGH Open

View full text Add to dashboard Cite

Gastrointestinal (GI) long‐COVID symptoms, including diarrhea and abdominal pain, have been reported in patients with long‐COVID. However, the clinical features of patients with GI long‐COVID symptoms remain unclear. We conducted a large‐scale prospective cohort study focusing on the clinical characteristics of patients with GI long‐COVID symptoms in Japan. Among 943 COVID‐19 patients, 58 patients (6.2%) had GI long‐COVID symptoms. The health‐related quality of life (QOL) parameters (the Short Form‐8 [SF‐8] and Euro Quality of Life 5 Dimensions 5 level [EQ‐5D‐5L]) at 12 months after diagnosis in patients with GI long‐COVID symptoms were significantly lower than in those without GI long‐COVID symptoms ( P < 0.0001). Moreover, patients with GI long‐COVID symptoms had more varied long‐COVID symptoms compared to patients without GI long‐COVID symptoms.

show abstract

Barriers to Engagement with Gastrointestinal Health Management

Kamp,

Gohres,

Tormey

et al. 2024

Dig Dis Sci

View full text Add to dashboard Cite

Background Although behavioral interventions have been effective in gastrointestinal (GI) conditions, barriers exist in implementing these interventions into clinical practice. The majority of previously published studies have focused on workforce limitations and have not considered individual and social determinants of health (SDoH) factors that can impact engagement in GI behavioral healthcare. Aims To characterize barriers to engagement in appointment attendance and health management, explore individual and SDoH factors impacting GI behavioral healthcare engagement, and identify barriers that occur more often for patients with SDoH-related vulnerability (low health literacy and/or financial insecurity). Methods A survey was distributed to adult patients who had been seen in Gastroenterology at the Dartmouth-Hitchcock Medical Center from June 2022 to December 2022. Results One hundred participants [mean age = 58 years, 57.1% women] completed the survey. SDoH vulnerability was present in 32.3% of the population. For the entire sample, 73% reported at least one barrier to accessing care and 75% reported at least one factor which impacted health management. Those with SDoH vulnerability reported significantly more barriers to attending appointments and to managing health. In addition, they were significantly more likely to endorse physical health problems, difficulty affording medical bills, pain, mobility issues, trauma experiences, significant stress, and difficulty with concentration. Conclusions Patients in a GI clinic reported multiple barriers to accessing care and participating in health management. Innovative, multi-level strategies are needed to address barriers to ensure that all patients are able to obtain quality GI behavioral health services.

show abstract

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study

Cited by 40 publications

References 35 publications

Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology

Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology

Clinical features of Japanese patients with gastrointestinal long‐COVID symptoms

Barriers to Engagement with Gastrointestinal Health Management

Contact Info

Product

Resources

About